About Contact Us Careers

Antiviral Drugs Market Share

Request Free Sample Copy

Report ID: 473
Published Date: Jul 22, 2024
Report Format: PDF, PPT

Buy Now

Antiviral Drugs Market Share

Regionally, the global antiviral drugs market is studied into five major regions including North America, Europe, Asia Pacific, Latin America and the Middle East & Africa region. Amongst these markets, the market in North America region is projected to hold the largest market share by the end of 2036 on the back of a growing patient base, the strong foothold of industry key players, increasing approval, and the expected commercialization of new drugs for viral diseases. In 2022, the number of COVID-19 cases increased by 8% in North America.

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:

Antiviral Drugs Market Size & Share, Growth Forecasts 2036

Author Credits: Radhika Pawar

Report ID: 473
Published Date: Jul 22, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of antiviral drugs is estimated at USD 56.13 Billion.

The antiviral drugs market size was over USD 54.13 Billion in 2023 and is poised to exceed USD 91.27 Billion by the end of 2036, growing at over 4.1% CAGR during the forecast period i.e., between 2024-2036. Rising cases of HIV, AIDS, Hepatitis, and STDs among adults are the major factors driving the market growth.

North America industry is predicted to hold majority revenue share by 2036, driven by growing patient base, the strong foothold of industry key players, increasing approval, and the expected commercialization of new drugs for viral diseases in the region.

AstraZeneca LP, F. Hoffmann-La Roche Ltd, GlaxoSmithKline, Plc, Bristol Myers Squibb Company, Abbott Laboratories, Plough Publishing House, Merck & Co., Inc, Johnson & Johnson Services, Inc, AbbVie Inc., Cipla Inc., Dr Reddy’s Laboratories Ltd.

Inquiry Before Buying Request Free Sample